Lv4
582 积分 2024-02-25 加入
Biological Therapies for Urate Lowering and Inflammation Control in Gout Management
1个月前
已完结
The Latest Progress in the Application of Telitacicept in Autoimmune Diseases
2个月前
已完结
Clinical trials and new therapies in Sjögren’s disease
2个月前
已完结
Case Series: Effectiveness and Safety of Telitacicept in Chinese Patients With Primary Sjögren's Disease
2个月前
已完结
Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study
2个月前
已完结
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies
2个月前
已完结
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome
2个月前
已完结
OP0041 Treatment of primary Sjögren's disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod
2个月前
已关闭
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
2个月前
已完结
Tyrosine kinase 2 inhibitors in autoimmune diseases
2个月前
已完结
皖公网安备34019202002308
